Felvizumab (SB 209763), a humanized IgG1kappa monoclonal antibody, targets specific neutralizing epitopes on the F glycoprotein of Respiratory Syncytial Virus (RSV) [1] [2].
CAS Number:
[167747-20-8]
* VAT and and shipping costs not included. Errors and price changes excepted